(Q84192358)

English

Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants

scientific article published on 06 July 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

multicenter clinical trial

1 reference

based on heuristic

inferred from title

0 references

Giuseppe Milone

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Iacopo Peccatori

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

A Bacigalupo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

T Lamparelli

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

M P Sormani

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

F Ciceri

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

A Locasciulli

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

I Majolino

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

P Di Bartolomeo

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

F Mazza

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

N Sacchi

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

S Pollicheni

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

V Pinto

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

M T Van Lint

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Gruppo Italiano Trapianto Midollo Osseo (GITMO)

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

6 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

45

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

385-391

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19584823%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathophysiology of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

Understanding the alloresponse: new approaches to graft-versus-host disease prevention.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of infliximab-daclizumab combination for the treatment of acute and chronic graft-versus-host disease of the liver and gut.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

Early predictors of transplant-related mortality (TRM) after allogeneic bone marrow transplants (BMT): blood urea nitrogen (BUN) and bilirubin

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

Pre-emptive therapy of acute graft-versus-host disease: a pilot study with antithymocyte globulin (ATG).

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

A revised day +7 predictive score for transplant-related mortality: serum cholinesterase, total protein, blood urea nitrogen, gamma glutamyl transferase, donor type and cell dose.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

Unrelated donor BMT recipients given pretransplant low-dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: a matched pair analysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study of the prevention of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.151

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84192358&oldid=2221546143"